NCAM1 and B-cell chronic lymphocytic leukemia: The results of such analysis of neoplastic PBMC for the patients with leukemias and lymphomas we have studied are presented in Tables S1–S3 and agree with flow cytometry results for the same patients including expression of CD2 in HCL, CD2 and CD11c in CLL, CD56 in MM (not shown).